Clinical Ink
Latest round
- —
Last raised
- Oct 2026
Total raised
- $30M
Investors
- 5
About Clinical Ink
Clinical Ink, Inc. is a US-based company specializing in innovative clinical trial solutions through its advanced eSource platform, enhancing data collection and patient engagement in clinical research. Clinical Ink, Inc. provides clinical trial solutions focusing on eSource technology, founded in 2007 and headquartered in Winston-Salem, US.40 mn in December 2020 from Clayton Associates. It has participated in six total deals to date. In September 2026, Ardan Equity, along with GI Partners, agreed to invest in Clinical Ink, Inc. Upon completion, each firm will own 50% majority shares. Clinical Ink specializes in a comprehensive suite of clinical trial solutions centered around its eSource platform, which integrates Direct Data Capture (DDC) technology and electronic Clinical Outcome Assessments (eCOA). This ecosystem unifies incoming data from diverse sources into a single platform, enhancing the efficiency and quality of clinical trial data across various phases and therapeutic areas, including neurology, infectious diseases, immunology, and oncology. Their services facilitate decentralized clinical trials, allowing direct data collection from patients and improving engagement.Clinical Ink's revenue model is built on B2B transactions with pharmaceutical companies and CROs, typically through subscription agreements or project-based contracts for services such as eCOA, DDC, and telehealth solutions. Their flagship offerings include the eLAS® Suite for lupus clinical trials and TrialLens™, a dashboard managing eCOA and connected device trials.Clinical Ink plans to develop new products and enhance its eSource platform to meet evolving client needs. The company targets expansion into new markets across Europe by the end of 2023.40 mn will support these initiatives, focusing on product innovation and market penetration. In December 2020, McKesson Ventures made a strategic investment in Clinical Ink, furthering its growth prospects.
Who invested in Clinical Ink
5 investors across 4 rounds
See all investors in Clinical Ink
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Clinical Ink
Who invested in Clinical Ink?
Clinical Ink has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Clinical Ink raised?
Clinical Ink has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
What does Clinical Ink do?
Clinical Ink is a healthcare it company.
Where is Clinical Ink headquartered?
Clinical Ink is headquartered in Winston-Salem, US.
Which VCs invest in companies like Clinical Ink?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Clinical Ink's stage. Their profiles are linked below.
VCs backing healthcare it startups
Raising like Clinical Ink? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.